Compare ImmunityBio Inc. Common Stock (IBRX) vs Global X NASDAQ 100 Covered Call ETF (QYLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Global X NASDAQ 100 Covered Call ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while Global X NASDAQ 100 Covered Call ETF trades at $18.69 (market cap $8.50B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, ImmunityBio Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Global X NASDAQ 100 Covered Call ETF for 50 Days on average.
| IBRX | QYLD | |
|---|---|---|
Market Cap | $10.33B | $8.50B |
Volume | 11,745,198 | 2,606,214 |
Sector | Health | Income / Options Overlay |
52-Week High | $11.55 | $18.68 |
52-Week Low | $1.98 | $16.70 |
Typical Hold Time | 0 Days | 50 Days |
Enterprise Value | $10.79B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QYLD trades at $18.68 with no daily change, showing a bullish technical trend per moving averages but overbought oscillators. The ETF maintains a high monthly dividend payout of $0.18, though recent news highlights concerns over capped upside and declining option premiums. Support and resistance cluster tightly around $19, indicating potential volatility near current levels.
Outlook remains mixed: high yield appeals for income, but structural limitations risk long-term capital erosion. Key risks include reduced Nasdaq participation and tax implications, while analyst sentiment is divided on sustainability versus growth trade-offs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →
